Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000050

CEO bought 700 shares at an average $0.01 ($5)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2019-09-24 Purchase : show line 1 in the form +100 $0.01 $1 25,330,397 D
2019-09-24 Purchase : show line 2 in the form +100 $0.01 $1 25,330,497 D
2019-09-25 Purchase : show line 3 in the form +100 $0.01 $1 25,330,597 D
2019-09-25 Purchase : show line 4 in the form +200 $0.01 $1 25,330,797 D
2019-09-25 Purchase : show line 5 in the form +200 $0.01 $1 25,330,997 D
Open-market purchases · 700 sh · avg $0.01 · $5
Loading xslF345X03/primary_doc.xml…